Actavis upgraded at RBC Capital As noted earlier, RBC Capital upgraded Actavis (ACT) to Top Pick from Outperform. The firm thinks the stock is well-positioned ahead of the closing of the company's acquisition of Forest Labs (FRX) mid-year, as it expects the combined company guidance to be an important catalyst. Target to $259 from $252.
News For ACT;FRX From The Last 14 Days
Check below for free stories on ACT;FRX the last two weeks.